Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBITDA: 2009-2024

Historic EBITDA for Geron (GERN) over the last 16 years, with Dec 2024 value amounting to -$173.7 million.

  • Geron's EBITDA rose 50.78% to -$13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.1 million, marking a year-over-year increase of 69.66%. This contributed to the annual value of -$173.7 million for FY2024, which is 10.42% up from last year.
  • According to the latest figures from FY2024, Geron's EBITDA is -$173.7 million, which was up 10.42% from -$193.9 million recorded in FY2023.
  • In the past 5 years, Geron's EBITDA ranged from a high of -$76.9 million in FY2020 and a low of -$193.9 million during FY2023.
  • Moreover, its 3-year median value for EBITDA was -$173.7 million (2024), whereas its average is -$168.7 million.
  • Per our database at Business Quant, Geron's EBITDA tumbled by 48.22% in 2021 and then climbed by 10.42% in 2024.
  • Over the past 5 years, Geron's EBITDA (Yearly) stood at -$76.9 million in 2020, then crashed by 48.22% to -$114.0 million in 2021, then declined by 21.54% to -$138.6 million in 2022, then plummeted by 39.98% to -$193.9 million in 2023, then increased by 10.42% to -$173.7 million in 2024.